Phase II Study of AP0302 5% Versus a Vehicle Comparator

Completed · Phase 2 · Has a placebo group

Conditions studied: Pain, Delayed Onset Muscle Soreness

In brief

This study is designed to evaluate the analgesic safety and efficacy of study drug (AP0302) applied topically every 6 hours as compared to a vehicle, in subjects experiencing delayed onset muscle soreness.

Key facts

Study ID

NCT02324985

Run by

Aponia Laboratories, Inc.

People needed

147

Starts

2015-01-01

Expected to finish

2016-06-01

Last updated by the study team

2019-02-25

Who can join

Age: 18 and older, up to 35. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• no clinically significant medical conditions
• BMI between 18-30
• negative drug, alcohol, pregnancy screens
• other protocol-defined inclusion criteria may apply

You may not qualify if…

• no upper extremity workout in last 6 months
• no job requiring heavy lifting
• history of muscle disorders
• allergy or intolerance to study drug
• history of recent pain medication use
• other protocol-defined exclusion criteria may apply

Where it is running

• Lotus Clinical Research, LLC — Pasadena, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.